Ohtaki et al used CD68 and CD204 as markers and researched TAMs in patients with lung cancer, with their results finding that CD204‐positive stromal TAMs but not CD68‐positive stromal TAMs are connected with tumour aggressiveness in lung cancer.15 This evidence concerns the gene CD68 and neoplasm.